[The treatment of choice for recurrent ameloblastoma].
92 patients with recurring ameloblastoma of jawbones were followed. The result after submitting these patients under preserving surgical therapy were evaluated on the basis of compared biostatistical and bioclinical criterion. Among these 92 patients, 66 were Negro African series with a success rate of 82% and 26 others were white "Caucasian" series with a success rate of 85%. What implies that the preserving surgery on the recurring ameloblastoma is more beneficial than negative with the two races with more than 80%. The authors thus concluded that this surgical method still keeps its place of choice in the treatment of the repetitions of the ameloblastoma and that this factor has a prognostic value.
Muvova
L
L
Service de Stomatologie et Chirurgie Maxillo-Faciale Cliniques, Universitaires de Kinshasa, Rép. Dém. du Congo.
Dilu
N
N
Sokolo
M
M
D000293:Adolescent; D000564:Ameloblastoma / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007573:Jaw Neoplasms / Q000601:surgery*; D009364:Neoplasm Recurrence, Local / Q000601:surgery*; D011446:Prospective Studies; D012086:Reoperation; D016896:Treatment Outcome